217 related articles for article (PubMed ID: 12796280)
1. Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension.
Furuhashi M; Ura N; Higashiura K; Murakami H; Tanaka M; Moniwa N; Yoshida D; Shimamoto K
Hypertension; 2003 Jul; 42(1):76-81. PubMed ID: 12796280
[TBL] [Abstract][Full Text] [Related]
2. Role of adiponectin in insulin-resistant hypertension and atherosclerosis.
Murakami H; Ura N; Furuhashi M; Higashiura K; Miura T; Shimamoto K
Hypertens Res; 2003 Sep; 26(9):705-10. PubMed ID: 14620925
[TBL] [Abstract][Full Text] [Related]
3. Blockade of the renin-angiotensin system decreases adipocyte size with improvement in insulin sensitivity.
Furuhashi M; Ura N; Takizawa H; Yoshida D; Moniwa N; Murakami H; Higashiura K; Shimamoto K
J Hypertens; 2004 Oct; 22(10):1977-82. PubMed ID: 15361770
[TBL] [Abstract][Full Text] [Related]
4. Circulating resistin levels in essential hypertension.
Furuhashi M; Ura N; Higashiura K; Murakami H; Shimamoto K
Clin Endocrinol (Oxf); 2003 Oct; 59(4):507-10. PubMed ID: 14510915
[TBL] [Abstract][Full Text] [Related]
5. Effects of the angiotensin converting enzyme inhibitor temocapril on insulin sensitivity and its effects on renal sodium handling and the pressor system in essential hypertensive patients.
Miyazaki Y; Murakami H; Hirata A; Fukuoka M; Masuda A; Ura N; Shimamoto K
Am J Hypertens; 1998 Aug; 11(8 Pt 1):962-70. PubMed ID: 9715789
[TBL] [Abstract][Full Text] [Related]
6. Association of insulin resistance and hyperinsulinemia with disturbed lipid metabolism in patients with essential hypertension.
Agata J; Miyazaki Y; Takada M; Murakami H; Masuda A; Miura T; Ura N; Shimamoto K
Hypertens Res; 1998 Mar; 21(1):57-62. PubMed ID: 9582109
[TBL] [Abstract][Full Text] [Related]
7. The effects of an angiotensin-converting enzyme inhibitor and an angiotensin II receptor antagonist on insulin resistance in fructose-fed rats.
Higashiura K; Ura N; Takada T; Li Y; Torii T; Togashi N; Takada M; Takizawa H; Shimamoto K
Am J Hypertens; 2000 Mar; 13(3):290-7. PubMed ID: 10777034
[TBL] [Abstract][Full Text] [Related]
8. Effects of angiotensin receptor antagonist and angiotensin converting enzyme inhibitor on insulin sensitivity in fructose-fed hypertensive rats and essential hypertensives.
Iimura O; Shimamoto K; Matsuda K; Masuda A; Takizawa H; Higashiura K; Miyazaki Y; Hirata A; Ura N; Nakagawa M
Am J Hypertens; 1995 Apr; 8(4 Pt 1):353-7. PubMed ID: 7619347
[TBL] [Abstract][Full Text] [Related]
9. Elevation of fatty acid-binding protein 4 is predisposed by family history of hypertension and contributes to blood pressure elevation.
Ota H; Furuhashi M; Ishimura S; Koyama M; Okazaki Y; Mita T; Fuseya T; Yamashita T; Tanaka M; Yoshida H; Shimamoto K; Miura T
Am J Hypertens; 2012 Oct; 25(10):1124-30. PubMed ID: 22717543
[TBL] [Abstract][Full Text] [Related]
10. Role of RAAS and adipokines in cardiovascular protection: effect of different doses of angiotensin II receptor blocker on adipokines level in hypertensive patients.
Hass A; Oz H; Mashavi M; Shargorodsky M
J Am Soc Hypertens; 2014 Oct; 8(10):709-14. PubMed ID: 25418492
[TBL] [Abstract][Full Text] [Related]
11. The effect of losartan and amlodipine on serum adiponectin in Japanese adults with essential hypertension.
Watanabe S; Okura T; Kurata M; Irita J; Manabe S; Miyoshi K; Fukuoka T; Murakami K; Higaki J
Clin Ther; 2006 Oct; 28(10):1677-85. PubMed ID: 17157123
[TBL] [Abstract][Full Text] [Related]
12. Blockade of the RAS increases plasma adiponectin in subjects with metabolic syndrome and enhances differentiation and adiponectin expression of human preadipocytes.
Tian F; Luo R; Zhao Z; Wu Y; Ban Dj
Exp Clin Endocrinol Diabetes; 2010 Apr; 118(4):258-65. PubMed ID: 19856251
[TBL] [Abstract][Full Text] [Related]
13. Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome.
Ducluzeau PH; Cousin P; Malvoisin E; Bornet H; Vidal H; Laville M; Pugeat M
J Clin Endocrinol Metab; 2003 Aug; 88(8):3626-31. PubMed ID: 12915646
[TBL] [Abstract][Full Text] [Related]
14. The contribution of skeletal muscle tumor necrosis factor-alpha to insulin resistance and hypertension in fructose-fed rats.
Togashi N; Ura N; Higashiura K; Murakami H; Shimamoto K
J Hypertens; 2000 Nov; 18(11):1605-10. PubMed ID: 11081773
[TBL] [Abstract][Full Text] [Related]
15. Low adiponectin level in young normotensive men with a family history of essential hypertension.
Furuhashi M; Ura N; Higashiura K; Miyazaki Y; Murakami H; Hyakukoku M; Shimamoto K
Hypertens Res; 2005 Feb; 28(2):141-6. PubMed ID: 16025741
[TBL] [Abstract][Full Text] [Related]
16. Telmisartan improves insulin resistance in high renin nonmodulating salt-sensitive hypertensives.
Sanchez RA; Masnatta LD; Pesiney C; Fischer P; Ramirez AJ
J Hypertens; 2008 Dec; 26(12):2393-8. PubMed ID: 19008718
[TBL] [Abstract][Full Text] [Related]
17. Telmisartan improves insulin sensitivity in nondiabetic patients with essential hypertension.
Benndorf RA; Rudolph T; Appel D; Schwedhelm E; Maas R; Schulze F; Silberhorn E; Böger RH
Metabolism; 2006 Sep; 55(9):1159-64. PubMed ID: 16919533
[TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory and metabolic effects of candesartan in hypertensive patients.
Koh KK; Quon MJ; Han SH; Chung WJ; Lee Y; Shin EK
Int J Cardiol; 2006 Mar; 108(1):96-100. PubMed ID: 16246439
[TBL] [Abstract][Full Text] [Related]
19. Vasopeptidase inhibitor omapatrilat induces profound insulin sensitization and increases myocardial glucose uptake in Zucker fatty rats: Studies comparing a vasopeptidase inhibitor, angiotensin-converting enzyme inhibitor, and angiotensin II type I receptor blocker.
Wang CH; Leung N; Lapointe N; Szeto L; Uffelman KD; Giacca A; Rouleau JL; Lewis GF
Circulation; 2003 Apr; 107(14):1923-9. PubMed ID: 12668518
[TBL] [Abstract][Full Text] [Related]
20. Fibrinolysis and insulin sensitivity in imidapril and candesartan (FISIC study) recipients with hypertension.
Fogari R; Zoppi A; Salvadeo SA; Mugellini A; Lazzari P; Santoro T; Derosa G
Hypertens Res; 2011 Apr; 34(4):509-15. PubMed ID: 21179101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
